Teleflex Incorporated (TFX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $6.15B
Last updated: Nov 17, 2026 at 11:06 AM ET
Teleflex Incorporated (TFX) Earnings: Report Dates and Results
Teleflex (TFX) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Teleflex reported EPS of $2.63, above the $1.92 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TFX has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 1.6% above the $1.93 reported for the quarter ended Dec 31, 2025.
TFX Earnings Call
The latest TFX earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, TFX beat 39 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $567.78M, up 0.1% from $566.95M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.63 | $1.92 | $1.76 - $2.04 | +36.98% | Beat | -28.3% | 11 | 0 up, 1 down | Nov 5, 2026 | $567.78M |
| Jun 30, 2026 | $1.76 | $1.28 | $1.22 - $1.49 | +37.50% | Beat | -52.8% | 13 | 0 up, 2 down | Aug 6, 2026 | $570.33M |
| Mar 31, 2026 | $1.39 | $1.21 | $1.15 - $1.33 | +14.88% | Beat | -52.2% | 9 | 1 up, 0 down | May 7, 2026 | $548.26M |
| Dec 31, 2025 | $1.93 | $3.73 | $3.55 - $4.08 | -48.26% | Miss | -50.4% | 10 | 0 up, 3 down | Feb 26, 2026 | N/A |
| Sep 30, 2025 | $3.67 | $3.38 | $3.34 - $3.58 | +8.58% | Beat | +5.2% | 12 | 4 up, 5 down | Nov 6, 2025 | $566.95M |
| Jun 30, 2025 | $3.73 | $3.37 | $3.24 - $3.42 | +10.68% | Beat | +9.1% | 11 | N/A | Jul 31, 2025 | $442.52M |
| Mar 31, 2025 | $2.91 | $2.88 | $2.71 - $3.18 | +0.89% | Beat | -9.3% | 12 | 1 up, 2 down | May 1, 2025 | $414.26M |
| Dec 31, 2024 | $3.89 | $3.88 | $3.77 - $3.98 | +0.26% | Beat | +15.1% | 12 | N/A | Feb 27, 2025 | N/A |
| Sep 30, 2024 | $3.49 | $3.39 | $3.32 - $3.48 | +2.95% | Beat | -4.1% | 13 | 0 up, 0 down | Oct 31, 2024 | $764.38M |
| Jun 30, 2024 | $3.42 | $3.33 | $3.30 - $3.37 | +2.70% | Beat | +0.3% | 14 | 1 up, 0 down | Aug 1, 2024 | $749.69M |
| Mar 31, 2024 | $3.21 | $3.07 | $3.04 - $3.13 | +4.56% | Beat | +3.9% | 14 | 0 up, 0 down | May 2, 2024 | $737.85M |
| Dec 31, 2023 | $3.38 | $3.26 | $3.20 - $3.36 | +3.68% | Beat | -4.0% | 14 | 0 up, 0 down | Feb 22, 2024 | N/A |
| Sep 30, 2023 | $3.64 | $3.27 | $3.18 - $3.33 | +11.31% | Beat | +11.3% | 14 | 1 up, 3 down | Nov 2, 2023 | $746.39M |
| Jun 30, 2023 | $3.41 | $3.21 | $3.11 - $3.34 | +6.23% | Beat | +0.6% | 15 | 1 up, 0 down | Aug 3, 2023 | $743.26M |
| Mar 31, 2023 | $3.09 | $2.98 | $2.80 - $3.11 | +3.69% | Beat | +7.3% | 14 | 0 up, 0 down | May 4, 2023 | $710.93M |
| Dec 31, 2022 | $3.52 | $3.44 | $3.36 - $3.51 | +2.33% | Beat | -2.2% | 14 | 0 up, 0 down | Feb 23, 2023 | $758.00M |
| Sep 30, 2022 | $3.27 | $3.11 | $3.00 - $3.26 | +5.14% | Beat | -6.8% | 14 | 0 up, 0 down | Oct 27, 2022 | $686.79M |
| Jun 30, 2022 | $3.39 | $3.34 | $3.28 - $3.40 | +1.50% | Beat | +1.2% | 12 | 0 up, 0 down | Jul 28, 2022 | $704.54M |
| Mar 31, 2022 | $2.88 | $2.72 | $2.69 - $2.96 | +5.88% | Beat | +0.3% | 10 | 1 up, 0 down | Apr 28, 2022 | $641.72M |
| Dec 31, 2021 | $3.60 | $3.53 | $3.49 - $3.59 | +1.98% | Beat | +10.8% | 10 | 1 up, 0 down | Feb 24, 2022 | $761.91M |
| Sep 30, 2021 | $3.51 | $3.03 | $2.95 - $3.11 | +15.84% | Beat | +26.7% | 11 | 0 up, 0 down | Oct 28, 2021 | $700.25M |
| Jun 30, 2021 | $3.35 | $2.87 | $2.66 - $2.93 | +16.72% | Beat | +73.6% | 10 | N/A | Jul 29, 2021 | $713.47M |
| Mar 31, 2021 | $2.87 | $2.42 | $2.37 - $2.67 | +18.59% | Beat | +5.5% | 11 | N/A | Apr 29, 2021 | $633.92M |
| Dec 31, 2020 | $3.25 | $3.05 | $2.99 - $3.09 | +6.56% | Beat | -0.9% | 11 | N/A | Feb 25, 2021 | $711.18M |
| Sep 30, 2020 | $2.77 | $2.24 | $2.03 - $2.43 | +23.66% | Beat | -6.7% | 11 | N/A | Oct 29, 2020 | $628.30M |
| Jun 30, 2020 | $1.93 | $1.25 | $1.01 - $1.77 | +54.40% | Beat | -27.4% | 13 | N/A | Jul 30, 2020 | $567.03M |
| Mar 31, 2020 | $2.72 | $2.24 | $1.93 - $2.50 | +21.43% | Beat | +21.4% | 12 | N/A | Apr 30, 2020 | $630.64M |
| Dec 31, 2019 | $3.28 | $3.22 | $3.18 - $3.27 | +1.86% | Beat | +18.4% | 13 | N/A | Feb 20, 2020 | $680.95M |
| Sep 30, 2019 | $2.97 | $2.75 | $2.72 - $2.83 | +8.00% | Beat | +17.9% | 13 | N/A | Oct 31, 2019 | $648.32M |
| Jun 30, 2019 | $2.66 | $2.59 | $2.54 - $2.66 | +2.70% | Beat | +7.7% | 13 | N/A | Aug 1, 2019 | $652.51M |
| Mar 31, 2019 | $2.24 | $2.17 | $2.15 - $2.22 | +3.23% | Beat | +4.2% | 12 | N/A | May 2, 2019 | $613.58M |
| Dec 31, 2018 | $2.77 | $2.76 | $2.71 - $2.83 | +0.36% | Beat | +13.5% | 13 | N/A | Feb 21, 2019 | $641.62M |
| Sep 30, 2018 | $2.52 | $2.42 | $2.36 - $2.46 | +4.13% | Beat | +18.9% | 12 | N/A | Nov 1, 2018 | $609.67M |
| Jun 30, 2018 | $2.47 | $2.41 | $2.36 - $2.45 | +2.49% | Beat | +21.1% | 11 | N/A | Aug 2, 2018 | $609.87M |
| Mar 31, 2018 | $2.15 | $1.94 | $1.92 - $1.97 | +10.82% | Beat | +19.4% | 11 | N/A | May 3, 2018 | $587.23M |
| Dec 31, 2017 | $2.44 | $2.40 | $2.37 - $2.46 | +1.67% | Beat | +14.6% | 12 | N/A | Feb 22, 2018 | $595.11M |
| Sep 30, 2017 | $2.12 | $2.00 | $1.95 - $2.08 | +6.00% | Beat | +17.8% | 11 | N/A | Nov 2, 2017 | $534.70M |
| Jun 30, 2017 | $2.04 | $1.91 | $1.89 - $1.93 | +6.81% | Beat | +7.9% | 11 | N/A | Aug 3, 2017 | $528.61M |
| Mar 31, 2017 | $1.80 | $1.69 | N/A | +6.51% | Beat | +18.4% | N/A | N/A | May 4, 2017 | $487.88M |
| Dec 31, 2016 | $2.13 | $2.09 | N/A | +1.91% | Beat | +6.0% | N/A | N/A | Feb 23, 2017 | $513.93M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $12.24, down 12.6% from the year before. It was $7.34 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $12.24 | -12.6% |
| Dec 31, 2024 | $14.01 | +3.6% |
| Dec 31, 2023 | $13.52 | +3.5% |
| Dec 31, 2022 | $13.06 | -2.0% |
| Dec 31, 2021 | $13.33 | +24.9% |
| Dec 31, 2020 | $10.67 | -4.3% |
| Dec 31, 2019 | $11.15 | +12.5% |
| Dec 31, 2018 | $9.91 | +18.0% |
| Dec 31, 2017 | $8.40 | +14.4% |
| Dec 31, 2016 | $7.34 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 14 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,234 | 14 | |
| 2026Q2 | Jun 30, 2026 | 8,234 | 15 | |
| 2026Q1 | Mar 31, 2026 | 6,683 | 14 | |
| 2025Q4 | Dec 31, 2025 | 5,658 | 13 | |
| 2025Q3 | Sep 30, 2025 | 5,631 | 11 | |
| 2025Q2 | Jun 30, 2025 | 7,023 | 12 | |
| 2025Q1 | Mar 31, 2025 | 8,077 | 15 | |
| 2024Q4 | Dec 31, 2024 | 8,848 | 15 |
2026Q3 Earnings Call
Opening remarks
Lawrence Keusch Vice President of Investor Relations and Strategy Development Good morning, everyone, and welcome to the Teleflex Incorporated Third Quarter 2026 Earnings Conference Call. The press release and slides to accompany this call are available on our website at teleflex.com. As a reminder, a replay will be available on our website. Those wishing to access the replay can refer to our press release from this morning for details. Joining me on today's call are Jason Weidman, President and Chief Executive Officer, and John Deren, Executive Vice President and Chief Financial Officer. Jason and John will provide prepared remarks, and then we will open the call to Q&A. Before we begin, I'd like to remind you that some of the matters discussed in the conference call will contain forward-looking statements regarding future events as outlined in the slides posted to the Investor Relations section of the Teleflex website. We wish to caution you that such statements are, in fact, forward-looking in nature and are subject to risks and uncertainties, and actual events or results may differ materially. The factors that could cause actual results or events to differ materially include, but are not limited to, factors referenced in our press release today as well as our filings with the SEC, including our Form 10-K, which can be accessed on our website. Now I'll turn the call over to Jason for his remarks.
Jason Weidman President and Chief Executive Officer Thank you, Larry, and good morning, everyone. Let me start this morning with the highlights of the quarter. Teleflex delivered strong third quarter performance with pro forma adjusted constant currency revenue growth of 3% and adjusted operating margin of 25%. Even excluding the benefit of the refund for IEEPA tariffs paid in 2026, adjusted margins saw modest expansion and earnings per share grew. Vascular and Surgical continued to deliver solid growth, while Interventional returned to positive growth, improving on its second quarter performance. We also continued our return of capital to shareholders with $350 million in additional share buybacks, $100 million more than previously announced between the beginning of Q3 and today. As John will discuss, we are increasing our full year adjusted EPS guidance to reflect our third quarter progress and our outlook for the remainder of the year. I've now been in the CEO role here at Teleflex for about 5 months. I've continued my extensive review of the organization, spent significant time visiting sites and customers across the globe, and ensured focus on our critical executional priorities. On our last call, I said I would have more to say about my perspective on the business and our future direction by this call.
Frequently Asked Questions About TFX
When is Teleflex's next earnings date?
Teleflex's next earnings report is expected for Feb 24, 2027.
Did TFX beat earnings estimates last quarter?
Yes. Teleflex reported EPS of $2.63 for the quarter ended Sep 30, 2026, above the $1.92 estimate, a 36.98% surprise.
What EPS do analysts expect from TFX next quarter?
The consensus EPS estimate for Teleflex for the quarter ending Dec 31, 2026 is $1.96 from 14 analysts, with estimates from $1.80 to $2.16.
How often does TFX beat earnings estimates?
Teleflex beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +7.69%.
TFX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts